Innovation
TheraPanacea: using artificial intelligence to improve the quality and access to cancer treatment and beyond
… over fifteen years of research at CentraleSupélec and Inria Saclay in partnership with the Institut Gustave Roussy. … director of the Centre for Digital Vision (CVN – Univ. Paris-Saclay, CentraleSupélec) and the Galen project team at … in contact with are already showing an interest in this new application component.” A solution for neurodegenerative …Published on: